SCHEMBL30199571

SCHEMBL30199571

Clc1cccc2c1CCNC2

nearest known ligand 0.72

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PNMT P11086 7/20 0.72
▸ CD44 P16070 2/20 0.61
▸ MAOB P27338 1/20 0.52
▸ HTR2C P28335 4/20 0.49
▸ ADRA2A P08913 2/20 0.47
▸ ADRA2B P18089 2/20 0.47
▸ ADRA2C P18825 2/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ ADRA1D P25100 1/20 0.47
▸ ADRA1A P35348 1/20 0.47
▸ ADRA1B P35368 1/20 0.47
▸ TAAR1 Q96RJ0 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ HTR2A P28223 2/20 0.44
▸ HTR2B P41595 2/20 0.44
▸ PRCP P42785 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2750868 1.00 PNMT (0.72) PNMTCD44MAOBHTR2CADRA2A
Hydrochloric Acid SCHEMBL1124563 0.98 PNMT (0.70) PNMTCD44MAOBHTR2CADRA2A
SCHEMBL11325485 0.89 PNMT (0.62) PNMTCD44MAOBHTR2CADRA2A
SCHEMBL10879871 0.86 PNMT (0.75) PNMTCD44HTR2CADRA2AADRA2B
SCHEMBL1852509 0.84 PNMT (1.00) PNMTCD44MAOBHTR2CADRA2A
Ammonia Solution, Strong SCHEMBL20358513 0.82 PNMT (0.96) PNMTCD44MAOBHTR2CADRA2A
Hydrochloric Acid SCHEMBL1124149 0.82 PNMT (0.96) PNMTCD44MAOBHTR2CADRA2A
SCHEMBL3171440 0.81 PNMT (0.68) PNMTCD44MAOBHTR2CADRA2A
SCHEMBL31158975 0.81 PNMT (0.68) PNMTCD44MAOBHTR2CADRA2A
Hydrochloric Acid SCHEMBL1636223 0.79 PNMT (0.66) PNMTCD44MAOBHTR2CADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115427409-B Pyrimidine-4 (3H) -one derivatives as TRPV4 antagonists 拉夸里亚创药株式会社 2025-02-25 — — CN disclosed
CN-115594669-B Parallel ring derivative and preparation method and medical application thereof 深圳信立泰药业股份有限公司 2024-11-05 — — CN disclosed
WO-2024201248-A1 COMPOUNDS AND METHODS FOR DEGRADING GSPT1 PIN THERAPEUTICS, INC. (KR) 2024-10-03 — — WO disclosed
CN-115594669-A Fused ring derivative and preparation method and medical application thereof 深圳信立泰药业股份有限公司(CN) 2023-01-13 — — CN disclosed
Send feedback